Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinsang series
- Development stage
- Unknown
- Lead developer
- Grand Beilin Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
The Jinsang series (金嗓系列), also known as the Golden Throat series, is a line of traditional Chinese medicine (TCM) products developed and marketed by Xi'an Beilin Pharmaceutical, a subsidiary of Grand Pharma (China Grand Pharmaceutical and Healthcare Holdings) under China Grand Enterprises. The series includes four core formulations: Jinsang Kaiyin (金嗓开音), Jinsang Qingyin (金嗓清音), Jinsang Liyan (金嗓利咽), and Jinsang Sanjie (金嗓散结), which are available in various dosage forms such as capsules, tablets, pills, and granules. These products are indicated for the treatment of various throat and ear, nose, and throat (ENT) conditions, including acute and chronic pharyngitis, laryngitis, hoarseness, vocal cord nodules, and vocal cord polyps. Jinsang Sanjie and Jinsang Kaiyin are listed on China's National Reimbursement Drug List (NRDL).
- Brand names
- Jinsang KaiyinJinsang LiyanJinsang QingyinJinsang Sanjie
- Other names
- Golden Throat seriesJinsang Series Products金嗓利咽金嗓开音金嗓散结金嗓清音金嗓系列
Beyond the preview
Go deeper on Jinsang series.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinsang series.